| editorial | Q871232 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Daniel Serón | |
| Jeremy R Chapman | |||
| Wolfgang Arns | |||
| P2860 | cites work | Structural and functional correlations in stable renal allografts | Q44423499 |
| Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions | Q44577528 | ||
| Poor predictive value of serum creatinine for renal allograft loss | Q44663038 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy | Q44800871 | ||
| Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years | Q44899016 | ||
| Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction | Q45057604 | ||
| De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. | Q45100299 | ||
| Performance of different prediction equations for estimating renal function in kidney transplantation | Q45100316 | ||
| Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study | Q46510645 | ||
| Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients | Q46763752 | ||
| Benefits of early biopsy on the outcome of kidney transplantation | Q46812692 | ||
| Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks | Q46856408 | ||
| Evolution of the renal function is a better predictor of long-term survival than serum creatinine. | Q46873832 | ||
| Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus | Q46936585 | ||
| Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy | Q46936599 | ||
| Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. | Q47206753 | ||
| The Banff 97 working classification of renal allograft pathology | Q59314413 | ||
| Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain | Q28343921 | ||
| Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis | Q31921311 | ||
| Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients | Q33968031 | ||
| Assessing kidney function--measured and estimated glomerular filtration rate | Q34535861 | ||
| Strategies to improve long-term outcomes after renal transplantation | Q34539775 | ||
| Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies | Q34546358 | ||
| Humoral theory of transplantation | Q35142603 | ||
| Pathways to nephron loss starting from glomerular diseases-insights from animal models | Q36021181 | ||
| Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens | Q36062030 | ||
| Workshop on late renal allograft dysfunction | Q36155832 | ||
| Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials | Q36155850 | ||
| Chronic renal allograft dysfunction | Q36240051 | ||
| What we CAN do about chronic allograft nephropathy: role of immunosuppressive modulations. | Q36326277 | ||
| The significance of subclinical rejection and the value of protocol biopsies | Q36517003 | ||
| How to estimate GFR-serum creatinine, serum cystatin C or equations? | Q36711754 | ||
| Limitations of glomerular filtration rate equations in the renal transplant patient | Q40441695 | ||
| The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates | Q41724238 | ||
| Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies | Q43889585 | ||
| Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation | Q43984395 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2467-2473 | |
| P577 | publication date | 2008-04-02 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Chronic allograft nephropathy--clinical guidance for early detection and early intervention strategies | |
| P478 | volume | 23 |
| Q38038696 | An evaluation of sirolimus in renal transplantation |
| Q91883185 | Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients |
| Q39282874 | Challenges and Considerations When Using Shear Wave Elastography to Evaluate the Transplanted Kidney, With Pictorial Review |
| Q38035660 | Chronic renal allograft injury: early detection, accurate diagnosis and management. |
| Q37120745 | Clinical Course and Outcomes of Late Kidney Allograft Dysfunction |
| Q40815282 | Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations |
| Q53154100 | Kidney transplant: usefulness of real-time elastography (RTE) in the diagnosis of graft interstitial fibrosis. |
| Q43175107 | Replacing calcineurin inhibitors with proliferation signal inhibitors after kidney transplantation: indications, results, and disadvantages |
| Q24187866 | Target of rapamycin inhibitors (TORi) as maintenance immunosuppression for kidney transplant recipients |
| Q24201591 | Target of rapamycin inhibitors (TORi) as maintenance immunosuppression for kidney transplant recipients |
| Q46351473 | Utility of Shear Wave Elastography for Assessing Allograft Fibrosis in Renal Transplant Recipients: A Pilot Study. |
Search more.